Surface Oncology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) and Vaccinex (NASDAQ:VCNX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends. Analyst Recommendations This is a summary of recent recommendations […]

The positive reaction to Coherus' sale of its ophthalmology franchise to Sandoz didn't last long.

The positive reaction to Coherus' sale of its ophthalmology franchise to Sandoz didn't last long.

According to PWC, "2023 was a reasonably strong year for the pharmaceutical and life sciences sector with both deal value and volume of M&A close to pre-pandemic levels."

– Launch of LOQTORZI offers first and only FDA-approved treatment for NPC in all lines of therapy – – Indicated in combination with chemotherapy for 1st line treatment and as monotherapy for...